Differentiation of influenza b virus lineages yamagata and victoria by real-time PCR by Biere, Barbara et al.
 
 
 
 
 
 
 
Originally published as: 
 
Biere, B., Bauer, B., Schweiger, B. 
Differentiation of influenza b virus lineages yamagata and victoria by real-time PCR 
(2010) Journal of Clinical Microbiology, 48 (4), pp. 1425-1427.  
 
DOI: 10.1128/JCM.02116-09 
 
 
The original publication is available at http://jcm.asm.org/cgi/content/abstract/48/4/1425 
 
Differentiation of Influenza B virus lineages Yamagata and Victoria by real-time 
PCR 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
 
Running title: Influenza B Yamagata / Victoria real-time PCR 
 
Barbara Biere *, Bettina Bauer, Brunhilde Schweiger 
 
Robert Koch-Institut, FG17 Influenza/Respiratorische Viren, Nordufer 20, 13353 
Berlin, Germany 
 
 
 
* Corresponding author:  Dr. Barbara Biere 
Nationales Referenzzentrum für Influenza 
FG 17 Influenza / Respiratorische Viren 
Robert Koch-Institut 
Nordufer 20 
13353 Berlin 
Tel.: +49 3018 754 2383 
Fax: +49 3018 754 2699 
E-mail: biereb@rki.de 21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
 
 
Keywords: Influenza B virus, hemagglutinine, Victoria lineage, Yamagata 
lineage, real-time PCR 
 
List of abbreviations 
PCR Polymerase Chain Reaction 
HIT Hemagglutination Inhibition Test 
MGB Minor Groove Binder 
HA Hemagglutination 
 2
1 
2 
3 
4 
5 
6 
Abstract 
Since the 1970ies, influenza B viruses diverge into two antigenically distinct virus 
lineages called Yamagata- and Victoria-lineage. We present the first real-time PCR 
assay for virus lineage discrimination to supplement the classical antigenic analyses. 
The assay was successfully applied to 310 primary samples collected in Germany 
from 2007 to 2009. 
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The influenza viruses are members of the Orthomyxoviridae family and are divided 
into three genera A, B and C (8). Influenza A and B viruses clinically are most 
relevant, since they cause severe respiratory infections in humans (2). While 
influenza A viruses comprise a large group of different subtypes (8), influenza B 
viruses used to form a homogenous group and only started to diverge into two 
antigenically distinguishable lineages in the 1970ies (3, 4, 6). These virus lineages 
were named after their first representatives, B/Victoria/2/87 and B/Yamagata/16/88, 
as Victoria- and Yamagata-lineage (6). Today, the antigenic differences between the 
lineages allow their discrimination by hemagglutination inhibition testing (HIT) using 
specific immune sera raised against contemporary strains of either lineage. However, 
HIT is a time-consuming and tedious process and needs virus isolation as a 
prerequisite. In contrast, PCR is well known to be a fast, specific and sensitive 
diagnostic method, and real-time PCR furthermore reduces the risk of carryover 
contamination and allows large-scale diagnostics (5). However, to date, no real-time 
PCR assay has been described which enables the differentiation of influenza B 
viruses, which would greatly speed up and thus improve influenza virus surveillance. 
We therefore present an assay which not only amplifies both lineages, but also 
discriminates between them by the application of two differently labelled minor 
groove binder (MGB) probes, either one being specific for one lineage.  
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The target region of the assay was chosen from an alignment with recent influenza B 
hemagglutinine database sequences (years 2000 – 2008). The 81bp amplicon 
comprises a 13bp stretch that differs in 6 positions between the two lineages. The 
stability of the characteristic nucleotide changes was confirmed by an alignment 
comprising all available influenza B hemagglutinine database sequences (1622 
sequences, years 1954 – 2008). The distinctive nucleotides have been stable from 
the late 1990ies until today, so that nucleotide changes are not impossible, but 
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unlikely to occur within the near future. Thus, an MGB probe was designed for either 
lineage targeting this 13bp stretch. By the application of both probes with different 
colour labels (FAM and VIC) in a single PCR reaction, both virus lineages can be 
detected and discriminated simultaneously, as only one of the two probes will give a 
fluorescence signal. 
Reaction conditions were established for the LightCycler 480 system in a total 
reaction volume of 25µL containing 1x PCR Buffer, 5mM MgCl2, 1.25µM dNTP 
(Invitrogen, USA) with dUTP (GE Healthcare, Great Britain), 0.5U Platinum Taq 
polymerase (Invitrogen, USA), 900nM of forward primer F432 (5’-
 ACCCTACARAMTTggAACYTCAgg -3’), 600nM of reverse primer R479 (5’-
 ACAgCCCAAgCCATTgTTg -3’), 150nM of Yamagata probe MGB437 (5’- 6FAM –
 AATCCgMTYTTACTggTAg – MGB -3’), 100nM of Victoria probe MGB470 (5’- VIC –
 ATCCgTTTCCATTggTAA – MGB -3’) and 3µL of template cDNA. Cycling conditions 
were 5min at 95°C, followed by 45 cycles of 15s at 95°C and 30s at 60°C. 
The assay was evaluated using two plasmids that were cloned according to routine 
procedures (1) and contained 610/613bp of the hemagglutinine gene of 
B/Bayern/7/08 (plasmid pYam) and B/Berlin/38/08 (plasmid pVic), two contemporary 
German isolates representing the Yamagata and Victoria lineage. Thus, the complete 
primer- and probe-binding regions represent the original sequences of these two 
isolates. Amplification of 10-fold serial dilutions of each plasmid in λ-DNA (1ng/µL) 
revealed a linear detection range from 107 to 102 genome equivalents per reaction 
with a correlation (R2) of >0.998 and a slope of -3.32 (pYam) and -3.33 (pVic) (Figure 
1A), resembling a PCR efficiency of 1 (E=10-1/slope – 1). We performed a probit 
analysis as a model of nonlinear regression that indicated a 95% detection probability 
of 24.4 genome equivalents per reaction for the pYam plasmid and 12.4 genome 
equivalents per reaction for pVic (Figure 1B). Additionally, from virus culture material 
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of the corresponding virus isolates B/Bayern/7/08 (Yamagata) and B/Berlin/38/08 
(Victoria) the 95% detection probability was determined to be 1.3x 10-5 and 3.8x 10-5 
HA units per reaction. The overall variability was assessed by repeat examination of 
three different plasmid copy numbers as well as virus culture material with a high, 
medium or low virus load. The standard deviations of Ct values were found to be very 
low and were comparable for Yamagata and Victoria viruses and plasmids (Table 1). 
We found no cross-reactivity with DNA/cDNA of isolates from seasonal influenza A 
virus subtypes H1N1 and H3N2, pandemic influenza A/H1N1, Respiratory Syncytial 
Virus A and B, Adenovirus serotypes 2, 3 and 4, Human Metapneumovirus, 
Parainfluenza viruses 1, 2 and 3, Coxsackievirus and Rhinovirus as well as human 
DNA from swab samples. 
Finally, to confirm the applicability of the assay in clinical diagnostics, we examined 
310 influenza B virus-positive primary samples from the influenza seasons 2007/08 
and 2008/09. All samples were taken from German patients presenting with 
influenza-like illness and successfully underwent HIT after virus isolation on MDCK2 
cells. The nasal and throat swabs were washed in MEM cell culture medium 
immediately after arrival. RNA was extracted using either the RTP DNA/RNA Virus 
Mini Kit (Invitek) or the MagAttract Viral RNA M48 Kit (Qiagen) according to the 
manufacturer’s suggestions. cDNA was synthesized from 25µL RNA applying the M-
MLV Reverse Transcriptase (Invitrogen) and random hexamer primers as described 
elsewhere (7). Residual RNA was stored at -80°C until further use.  
Applying the presented assay, viruses were amplified from all 310 primary samples 
with Ct values between 22 and 37. All samples were genetically identified as 
Yamagata- or Victoria-lineage viruses in concordance with HIT results. The 310 
primary samples comprised 185 Yamagata and 3 Victoria lineage viruses from the 
season 2007/08 as well as 120 Victoria and 2 Yamagata lineage viruses from the 
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season 2008/09. Since the assay’s introduction into our diagnostic routine in 
February 2009, it has been run on approximately 5000 samples, and to our 
knowledge no false-positive or false-negative results have been obtained. 
In summary, we present the first real-time PCR assay for the differentiation of 
influenza B viruses. This assay considerably speeds up virus lineage identification in 
clinical specimens and therefore will help to improve the surveillance of influenza B 
viruses. Furthermore, it will enable a timely recognition of the circulating B virus 
lineage during influenza seasons and thus will allow short-term decisions on patient 
care, e.g. in case of a non-matching vaccine, as well as the early onset of on-time 
epidemiological examinations, including WHO decisions on vaccine composition. 
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Figure Legends 
 
Table 1 PCR assay validation: Detection variability 3 
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Variability runs were performed by examination of pYam and pVic plasmid dilutions 
(5x 105, 5x 103, 5x 101 genome equivalents per reaction) as well as on cultured virus 
material with high (6.67x 108 genome copies/ml), medium (6.67x 106 genome 
copies/ml) or low virus load (6.67x 104 genome copies/ml). Intraassay variability was 
tested in sextuplicate reactions. Interassay variability was determined by twofold 
examination of duplicate reactions under inclusion of data from the intraassay 
variability run (total: threefold examination). The standard deviations (SD) of obtained 
Ct values are listed. 
 
 
Figure 1 PCR assay validation 14 
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(A) Mean Ct values (double reactions) of plasmid dilutions containing 10
7 – 102 
genome equivalents of pYam and pVic were plotted against the cycle number. 
Slope and correlation (R2) are indicated. 
(B) Probit analyses were performed by examination of plasmid dilutions containing 
100 – 0.1 genome equivalents of pYam and pVic in tenfold reactions. Results 
were analyzed using the SPSS 17.0 statistics software. 
